Pfizer Inc. (NYSE:PFE) | Pfizer And GlaxoSmithKline: Aiming For Melanoma Cure Supremacy

[at Seeking Alpha] – To enhance the safety and efficacy profile of its probable future blockbuster cancer drug, “Palbociclib,” Pfizer ( PFE ) collaborated with GlaxoSmithKline ( GSK ) . The company will . . . → Read More: Pfizer Inc. (NYSE:PFE) | Pfizer And GlaxoSmithKline: Aiming For Melanoma Cure Supremacy Similar posts: Pfizer Inc. (NYSE:PFE) | Pfizer and GSK to Initiate Study of Novel Combination Therapy in Patients with Melanoma Microsoft Corporation (NYSE:MSFT) | Microsoft spending $405 million on Windows marketing, aiming for 16 million tablet sales Pfizer Vs. Novartis: A New Era In Breast Cancer Treatment – Pfizer Inc. (NYSE:PFE)